Transchem Ltd (TRANSCHEM) is currently trading at 376.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Transchem Limited initially engaged in chemicals and pharmaceuticals, transitioned toward mushroom production, operating a 100% Export Oriented Unit in Pune. However, this plant became non-operational due to changes in the horticulture industry. The company manufactures bulk drugs primarily in Maharashtra, with frusemide, fenbendazole, and albendazole as key products. Transchem has signed a Memorandum of Understanding with a Dutch company for its mushroom project, previously entering into agreements for technical collaborations. Previously, Transchem was recognized for its mushroom cultivation and international sales of various compounds, including Diminazine Aceturate and Triclabendazole. In 2008, the company exited the pharmaceutical division, indicating a strategic shift away from that sector.

Over the past 52 weeks, Transchem Ltd has traded between a low of ₹47.52 and a high of ₹384.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Transchem Ltd has a market capitalization of approximately 448.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Transchem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 66.76 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 448.60 Cr, Transchem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Transchem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Transchem Ltd is 66.76. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The 49th AGM is scheduled for Saturday, September 05, 2026 at 11:00 a.m. (IST) and will be held via video conferencing (VC) or other audio-visual means (OAVM).